Literature DB >> 15897908

Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium.

Anja Saalbach1, Anne Wetzel, Uwe-Frithjof Haustein, Michael Sticherling, Jan C Simon, Ulf Anderegg.   

Abstract

The expression of the alphavbeta3 integrin (CD51/CD61) on human melanoma cells has been shown to be associated most closely with tumor progression and metastases formation in melanoma. Here, we demonstrated a specific interaction of the alphavbeta3 integrin on melanoma cells with the human Thy-1, an inducible cell adhesion molecule expressed on the cell surface of activated endothelial cells (EC). The interaction was shown by the binding of purified Thy-1 protein to alpha(V)beta(3) transfected cells, to alphavbeta3-expressing melanoma cells and to purified alpha(V)beta(3) integrin. Moreover, melanoma cells adhere specifically to Thy-1 transfectants via alphavbeta3 on melanoma cells showing the functional relevance of this interaction for cell adhesion. Finally, the importance of the alphavbeta3/Thy-1 interaction for the adhesion of melanoma cells to the activated endothelium was confirmed under static and flow conditions by the inhibition of melanoma cell adhesion to and transmigration across activated EC by blocking the alphavbeta3/Thy-1 interaction. In conclusion, we have identified a new pair of adhesion molecules Thy-1 and alphavbeta3 mediating the interaction of melanoma cells and activated EC. These data explain at least in part the high tumorigenicity of alphavbeta3-expressing melanoma cells and the association of alphavbeta3-positive melanoma cells with a high risk of metastasis and poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897908     DOI: 10.1038/sj.onc.1208559

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  41 in total

Review 1.  Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype.

Authors:  John E Bradley; Gustavo Ramirez; James S Hagood
Journal:  Biofactors       Date:  2009 May-Jun       Impact factor: 6.113

2.  Quantitative analysis of surface plasma membrane proteins of primary and metastatic melanoma cells.

Authors:  Haibo Qiu; Yinsheng Wang
Journal:  J Proteome Res       Date:  2008-04-15       Impact factor: 4.466

3.  Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1.

Authors:  Manuela Schmidt; Danny Gutknecht; Jan C Simon; Jan-Niklas Schulz; Beate Eckes; Ulf Anderegg; Anja Saalbach
Journal:  J Invest Dermatol       Date:  2015-03-04       Impact factor: 8.551

4.  Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium.

Authors:  Giorgia Jurisic; Maria Iolyeva; Steven T Proulx; Cornelia Halin; Michael Detmar
Journal:  Exp Cell Res       Date:  2010-06-23       Impact factor: 3.905

Review 5.  Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses.

Authors:  Tanya A Rege; James S Hagood
Journal:  Biochim Biophys Acta       Date:  2006-08-18

6.  Direct Thy-1/alphaVbeta3 integrin interaction mediates neuron to astrocyte communication.

Authors:  Tamara Hermosilla; Daniel Muñoz; Rodrigo Herrera-Molina; Alejandra Valdivia; Nicolás Muñoz; Sang-Uk Nham; Pascal Schneider; Keith Burridge; Andrew F G Quest; Lisette Leyton
Journal:  Biochim Biophys Acta       Date:  2008-02-20

7.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.

Authors:  Yong Zhou; Katri Koli; James S Hagood; Mi Miao; Mahendra Mavalli; Daniel B Rifkin; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

8.  Thy-1-mediated cell-cell contact induces astrocyte migration through the engagement of αVβ3 integrin and syndecan-4.

Authors:  Milene Kong; Nicolás Muñoz; Alejandra Valdivia; Alvaro Alvarez; Rodrigo Herrera-Molina; Areli Cárdenas; Pascal Schneider; Keith Burridge; Andrew F G Quest; Lisette Leyton
Journal:  Biochim Biophys Acta       Date:  2013-02-26

9.  Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

Authors:  Michelle L Churchman; Jonathan Low; Chunxu Qu; Elisabeth M Paietta; Lawryn H Kasper; Yunchao Chang; Debbie Payne-Turner; Mark J Althoff; Guangchun Song; Shann-Ching Chen; Jing Ma; Michael Rusch; Dan McGoldrick; Michael Edmonson; Pankaj Gupta; Yong-Dong Wang; William Caufield; Burgess Freeman; Lie Li; John C Panetta; Sharyn Baker; Yung-Li Yang; Kathryn G Roberts; Kelly McCastlain; Ilaria Iacobucci; Jennifer L Peters; Victoria E Centonze; Faiyaz Notta; Stephanie M Dobson; Sasan Zandi; John E Dick; Laura Janke; Junmin Peng; Kiran Kodali; Vishwajeeth Pagala; Jaeki Min; Anand Mayasundari; Richard T Williams; Cheryl L Willman; Jacob Rowe; Selina Luger; Ross A Dickins; R Kiplin Guy; Taosheng Chen; Charles G Mullighan
Journal:  Cancer Cell       Date:  2015-08-27       Impact factor: 31.743

10.  A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium.

Authors:  Sabreena Safuan; Sarah J Storr; Poulam M Patel; Stewart G Martin
Journal:  Lymphat Res Biol       Date:  2012-12-05       Impact factor: 2.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.